Myriad Genetics (MYGN) EBT Margin Growth (1y) (2010 - 2026)
Myriad Genetics (MYGN) EBT Margin Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 30.00 |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | 617.00 |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 163.00 |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 665.00 |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | -115.00 |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | 113.00 |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | -646.00 |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 288.00 |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | -37.00 |
| 10 | Myriad Genetics | 297.97 Mn | 173.57 Mn | 137.60 Mn | -201.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -201.00 |
| Dec 31, 2025 | 1,432.00 |
| Sep 30, 2025 | -280.00 |
| Jun 30, 2025 | -13,755.00 |
| Mar 31, 2025 | -220.00 |
| Dec 31, 2024 | -214.00 |
| Sep 30, 2024 | 2,195.00 |
| Jun 30, 2024 | 4,568.00 |
| Mar 31, 2024 | 1,622.00 |
| Dec 31, 2023 | 1,287.00 |
| Sep 30, 2023 | -363.00 |
| Jun 30, 2023 | -5,329.00 |
| Mar 31, 2023 | -1,302.00 |
| Dec 31, 2022 | -225.00 |
| Sep 30, 2022 | -5,205.00 |
| Jun 30, 2022 | -798.00 |
| Mar 31, 2022 | 1,264.00 |
| Dec 31, 2021 | 434.00 |
| Sep 30, 2021 | 8,177.00 |
| Jun 30, 2021 | 7,171.00 |